#30DaysofTeal: September 1st
#30DaysofTeal: September 1st
Help us tell 100,000 women the symptoms of ovarian cancer. Share our graphic and a link to on social media today. Learn more about the symptoms of ovarian cancer.
News
Presidential Proclamation from President Obama
Presidential Proclamation from President Obama
Today, President Obama Declares September National Ovarian Cancer Awareness Month. “Today, cancer research is on the cusp of major breakthroughs, and it is of critical national importance that we accelerate this progress and keep reaching for prevention, treatment, and a cure. Each September, in honor of the women who have been taken by ovarian cancer … Continued
September is Ovarian Cancer Awareness Month #30DaysofTeal
September is Ovarian Cancer Awareness Month #30DaysofTeal
Follow OCRFA on Facebook, Twitter and Instagram and join the conversation at #30DaysofTeal! September 1: Help us tell 100,000 women the symptoms of ovarian cancer. Share our graphic and link on social media today. Learn more about the symptoms of ovarian cancer. P.S. – Wear Teal Day is TOMORROW! Don’t forget to wear your best … Continued
SGO and ASCO Agree on Guidelines for Common Type of Ovarian...
SGO and ASCO Agree on Guidelines for Common Type of Ovarian Cancer
(August 16, 2016) While primary cytoreductive surgery followed by chemotherapy is the standard of care for newly diagnosed women with advanced ovarian cancer, newly issued practice guidelines suggest that some patients may benefit more from first-line neoadjuvant chemotherapy (NACT) and followed by surgery. Last week, the Society for Gynecologic Oncology (SGO) and the American Society … Continued
Super Saturday Events Raise Close to $3.5 Million for OCRFA
Super Saturday Events Raise Close to $3.5 Million for OCRFA
Donna Karan, Kelly Ripa and Gabby Karan de Felice hosted Ovarian Cancer Research Alliance’s (OCRFA) 19th annual Super Saturday NY. Guests in attendance included: June Ambrose, Joy Behar, Kelly Bensimon, Lorraine Bracco, Jonathan Cheban, Mayor Rudolph & Judith Giuliani, Katherine Jenkins, Star Jones, Congresswoman Carolyn Maloney, Rebecca Minkoff, Cathy Moriarty-Gentile, Elin Nordegren, Molly Sims, Jill … Continued
September Partner Member Events
View events happening across the country during September, National Ovarian Cancer Awareness month!
Super Saturday Events Raise Close to $3.5 Million for OCRFA
Donna Karan, Kelly Ripa and Gabby Karan de Felice hosted Ovarian Cancer Research Alliance’s (OCRFA) 19th annual Super Saturday NY. Guests in attendance included: June Ambrose, Joy Behar, Kelly Bensimon, Lorraine Bracco, Jonathan Cheban, Mayor Rudolph & Judith Giuliani, Katherine Jenkins, Star Jones, Congresswoman Carolyn Maloney, Rebecca Minkoff, Cathy Moriarty-Gentile, Elin Nordegren, Molly Sims, … Continued
Impact of Genetic Counseling on Testing and Surgical Preven...
Impact of Genetic Counseling on Testing and Surgical Prevention in High Risk Women
(Aug 1. 2016) Results of a study reported last month in Cancer show that routine referral of women at high risk for ovarian cancer to genetic counseling promotes genetic testing and prophylactic surgery. Guidelines recommend genetic counseling and testing for women who have a pedigree suggestive of an inherited susceptibility for ovarian cancer (for example, … Continued
Women Still Getting CA-125 and CT Testing After Ovarian Can...
Women Still Getting CA-125 and CT Testing After Ovarian Cancer, Despite Lack of Clear Benefit
(July 28, 2016) A study published recently in JAMA Oncology showed that CA-125 tests and CT scans are routinely used in ovarian cancer surveillance testing, even though evidence has shown there is no clinical benefit to using these tests. There is no consensus on how to follow a patient in remission from ovarian cancer in … Continued
Research Study: Meditation
Research Study: Meditation
Dr. Anne Reb at Walter Reed National Military Medical Center is currently looking for participants in her research study for women who have been diagnosed with Stage 3 or 4 ovarian cancer and have completed their primary treatment within the last four months and have no clinical evidence of disease. The study will teach you … Continued
New Treatment Shows No Benefit for Clear Cell Carcinoma
New Treatment Shows No Benefit for Clear Cell Carcinoma
(July 18, 2016) The first randomized phase III clinical trial to compare irinotecan and cisplatin with paclitaxel plus carboplatin in patients with clear cell carcinoma (CCC) of the ovary found no significant survival benefit between the groups. The findings of the study, which was conducted in Japan, were reported in the Journal of Clinical Oncology. … Continued
Study Finds Many Ovarian Cancer Patients Going Untreated
Study Finds Many Ovarian Cancer Patients Going Untreated
(July 6, 2016) Gynecologic Oncology recently published a study that found that, although surgery leads to longer survival rates, many ovarian cancer patients are not undergoing surgery, and some are not being treated at all. The researchers analyzed data from more than 210,000 women diagnosed with ovarian cancer in the United States between 2003 and … Continued